Related Experiment Video
Updated: Apr 15, 2026
09:47
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
10.3K
Dendritic core-shell systems as soft drug delivery nanocarriers.
Maike C Lukowiak1, Bala N S Thota1, Rainer Haag1
1Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany.
Biotechnology Advances
|April 15, 2015
Summary
Unimolecular micelles, stable dendritic core-shell systems, show great promise for advanced drug delivery applications in nanomedicine. This review highlights recent advances in their design and use.
Area of Science:
- Polymer Chemistry
- Nanomedicine
- Materials Science
Background:
- Unimolecular micelles are covalently bound molecular architectures offering high stability.
- Their stability makes them highly attractive for drug delivery systems.
- Numerous studies highlight the significance of these architectures in nanomedicine.
Purpose of the Study:
- To review recent advances in the application of unimolecular micelles for drug delivery.
- To discuss dendritic core-shell systems used as unimolecular micelles.
- To categorize these systems based on core nature and structure.
Main Methods:
- Conceptual review of existing literature.
- Analysis of unimolecular micelles based on hyperbranched and dendritic cores.
- Classification of systems by core composition and structural features.
Main Results:
- Dendritic core-shell unimolecular micelles represent a significant advancement in drug delivery.
- The stability of these structures is crucial for effective therapeutic applications.
- Recent research demonstrates diverse applications and tailored designs for specific needs.
Conclusions:
- Unimolecular micelles, particularly dendritic core-shell types, are highly promising for advanced drug delivery.
- Their inherent stability and tunable structures facilitate targeted and effective nanomedicine solutions.
- Continued research into their design and application will further unlock their potential in treating diseases.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127
01:27Drug Delivery Systems: Different Types
322
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
322
01:24Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
01:16Drug Delivery: Overview
1.2K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.2K
01:19Modified-Release Drug Delivery Systems: Overview
197
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
197
01:11Oral Drug Delivery Systems: Delayed-Release Systems
180
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
180